APA (7th ed.) Citation

BR, L., MJ, R., AM, N., K, B., MJ, N., GA, F., . . . FS, B. (2026). Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds. Journal of psychopharmacology (Oxford, England), 40(5), 667. https://doi.org/10.1177/02698811251413490

Chicago Style (17th ed.) Citation

BR, Lewis, et al. "Challenges with Clinical Trial Participants in Studies with Classical Psychedelics: A Position Statement from the National Network of Depression Centers' Task Group on Psychedelics and Related Compounds." Journal of Psychopharmacology (Oxford, England) 40, no. 5 (2026): 667. https://doi.org/10.1177/02698811251413490.

MLA (9th ed.) Citation

BR, Lewis, et al. "Challenges with Clinical Trial Participants in Studies with Classical Psychedelics: A Position Statement from the National Network of Depression Centers' Task Group on Psychedelics and Related Compounds." Journal of Psychopharmacology (Oxford, England), vol. 40, no. 5, 2026, p. 667, https://doi.org/10.1177/02698811251413490.